Evaluation of the efficacy and safety of hydroxychloroquine in comparison with chloroquine in moderate and severe patients with COVID-19.
Li Q, Cui C, Xu F, Zhao J, Li N, Li H, Wang T, Zhang H, Liu N, Wei Y, Niu X, Xu Y, Dong J, Yao X, Wang X, Chen Y, Li H, Song C, Qiao J, Liu D, Shen N.
Li Q, et al.
Sci China Life Sci. 2021 Apr;64(4):660-663. doi: 10.1007/s11427-020-1871-4. Epub 2021 Jan 18.
Sci China Life Sci. 2021.
PMID: 33471276
Free PMC article.
No abstract available.